Ellen Kaufman
Endocrinology, Diabetes & Metabolism Albuquerque, NM Medical Doctor
NPI 1699869073 CMS profile 76502
201 Cedar St Se Ste 4640, Pmg Cedar Endocrinology, Albuquerque, NM 87106
General payments
$30
Research payments
$0
Ownership & investment interest
$0
Through program year 2019, Ellen Kaufman of Albuquerque, NM is reported in the CMS Open Payments database as having received $30 across 2 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 4th percentile of Endocrinology, Diabetes & Metabolism profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
1 row| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2019 | General | $30 | 2 |
Beside peers
- Ellen Kaufman
- Endocrinology, Diabetes & Metabolism median
- Middle half of Endocrinology, Diabetes & Metabolism
- National median
In program year 2025, general payments to Ellen Kaufman were reported at $0. Among 5,868 Endocrinology, Diabetes & Metabolism profiles paid that year, the median was $507 and the middle half received between $135 and $1,838.
Show as a table
| Year | Ellen Kaufman | Endocrinology, Diabetes & Metabolism median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $30 | $494 | $123–$2,253 | $163 |
| 2020 | $0 | $335 | $85–$1,841 | $114 |
| 2021 | $0 | $398 | $88–$1,981 | $132 |
| 2022 | $0 | $364 | $88–$1,568 | $149 |
| 2023 | $0 | $420 | $113–$1,614 | $160 |
| 2024 | $0 | $440 | $121–$1,646 | $164 |
| 2025 | $0 | $507 | $135–$1,838 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
2 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Endocrinology, Diabetes & Metabolism in New Mexico
Robert Ferraro
Endocrinology, Diabetes & Metabolism · Albuquerque, NM
Rina Patel Trujillo
Endocrinology, Diabetes & Metabolism · Albuquerque, NM
Jeremy Gleeson
Endocrinology, Diabetes & Metabolism · Albuquerque, NM
David Schade
Endocrinology, Diabetes & Metabolism · Albuquerque, NM
Mansi Mehta
Endocrinology, Diabetes & Metabolism · Albuquerque, NM
Matthew Bouchonville
Endocrinology, Diabetes & Metabolism · Albuquerque, NM
Related records
Endocrinology, Diabetes & Metabolism in New Mexico
Practitioners in the same specialty and state, ranked by reported value.
All Endocrinology, Diabetes & Metabolism
Everyone recorded under this specialty, nationwide.
Doctors in New Mexico
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.